1246203-35-9

1246203-35-9 structure
1246203-35-9 structure

Name N-[4-[4-[2-(difluoromethyl)-4-methoxybenzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]phenyl]ethenesulfonamide
Synonyms N-(4-{4-[2-(Difluoromethyl)-4-methoxy-1H-benzimidazol-1-yl]-6-(4-morpholinyl)-1,3,5-triazin-2-yl}phenyl)ethenesulfonamide
Ethenesulfonamide, N-[4-[4-[2-(difluoromethyl)-4-methoxy-1H-benzimidazol-1-yl]-6-(4-morpholinyl)-1,3,5-triazin-2-yl]phenyl]-
N-(4-(4-(2-(difluoromethyl)-4-methoxy-1H-benzo[d]imidazol-1-yl)-6-morpholino-1,3,5-triazin-2-yl)phenyl)ethenesulfonamide
N-{4-[4-[2-(difluoromethyl)-4-methoxy-1H-benzimidazol-1-yl]-6-(4-morpholinyl)-1,3,5-triazin-2-yl]phenyl}ethylenesulfonamide
N-(4-(4-(2-(difluoromethyl)-4-methoxy-1H-benzimidazol-1-yl)-6-(4-morpholinyl)-1,3,5-triazin-2-yl)phenyl)vinylsulfonamide
Density 1.5±0.1 g/cm3
Boiling Point 755.2±70.0 °C at 760 mmHg
Molecular Formula C24H23F2N7O4S
Molecular Weight 543.546
Flash Point 410.5±35.7 °C
Exact Mass 543.150024
PSA 132.74000
LogP 2.50
Vapour Pressure 0.0±2.5 mmHg at 25°C
Index of Refraction 1.681

~%

1246203-35-9 structure

1246203-35-9

Literature: PATHWAY THERAPEUTICS INC.; REWCASTLE, Gordon, William; GIDDENS, Anna, Claire; GAMAGE, Swarnalatha, Akuratiya Patent: WO2012/44641 A1, 2012 ; Location in patent: Page/Page column 46; 82-84 ; WO 2012/044641 A1

~%

1246203-35-9 structure

1246203-35-9

Literature: PATHWAY THERAPEUTICS INC.; REWCASTLE, Gordon, William; GIDDENS, Anna, Claire; GAMAGE, Swarnalatha, Akuratiya Patent: WO2012/44641 A1, 2012 ; WO 2012/044641 A1

~%

1246203-35-9 structure

1246203-35-9

Literature: PATHWAY THERAPEUTICS INC.; REWCASTLE, Gordon, William; GIDDENS, Anna, Claire; GAMAGE, Swarnalatha, Akuratiya Patent: WO2012/44641 A1, 2012 ; WO 2012/044641 A1
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.